International Paper's ongoing cost-cutting and facility rationalization post-DS Smith acquisition position it for outsized profitability despite sector-wide macro headwinds. Current financials are messy due to restructuring, but margin expansion and improved sales execution signal underlying operational progress and future self-help upside. Free cash flow is temporarily depressed by one-time integration costs, but management guidance and cost improvements support a strong rebound in 2025 and beyond.

Ketamine faces a current US drug shortage not expected to abate in the near future1 Current ketamine market estimated at $750 million and projected to reach $3.35 billion globally in 2034.2 NRx anticipates marketing ketamine for all approved uses Company anticipates priority review based on current and anticipated drug shortage NRX-100 to provide innovative, preservative-free IV ketamine formulation to eliminate benzethonium chloride preservative, in keeping with current HHS priorities to eliminate toxic preservatives from foods and drugs The Company anticipates filing a citizen's petition with the FDA to remove benzethonium chloride, a known neurotoxic and cytotoxic substance, from all presentations …

Stagwell's digital transformation offerings and aggressive M&A strategy are driving revenue growth, with further inorganic expansion likely through 2027. The company benefits from a booming digital transformation market and recent high-profile client wins, supporting strong future revenue prospects. Risks include client concentration, lack of long-term contracts, foreign currency exposure, and control by the CEO, but these are outweighed by upside potential.

CNBC's Leslie Picker and TPG Executive Chairman Jim Coulter join 'Squawk Box' to discuss the state of the private equity industry, investment opportunities in Europe, evolution in ESG strategy, and more.

AUSTIN, Texas--(BUSINESS WIRE)---- $AMD #AI--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSai™ platform powered by their patented HYFT® technology. This discovery, made using several proprietary HYFT-based analyses, identifies a part of the virus (an epitope) that has remained unmutated across all four known virus serotypes, therefore potentially allowi.

OSHKOSH, Wis.--(BUSINESS WIRE)---- $OSK #NYSE--Oshkosh Corporation (NYSE: OSK), a leading innovator of purpose-built vehicles and equipment, is hosting its Investor Day today, June 5, 2025, at the New York Stock Exchange beginning at 9:30 a.m. EDT. Register for the full live event here: Live webcast (register/join). The presentations will provide an in-depth review of Oshkosh's business strategy, growth drivers and financial objectives. During the event, there will be an opportunity for both live and webcast.

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, and Mala Murthy, chief financial officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Wednesday, June 11th, 2025, at 9:20 a.m. ET. A live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations.

Magnite is first SSP to integrate ContextIQ to help bring contextual targeting and planning powered by multimodal AI to CTV advertising Magnite is first SSP to integrate ContextIQ to help bring contextual targeting and planning powered by multimodal AI to CTV advertising

BOTHELL, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS) being held August 4-7 in Kissimmee, Fla.

Bowie, Md., June 05, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, has announced that it has named Michael Bercovich as its new Chief Financial Officer. Bercovich, who will officially assume the CFO role at Blink on June 23rd, previously served as Chief Financial Officer at Helios Global Payments Solutions, MyOutDesk, Cialfo and Elements Global Services, where he led variety of functions, such as finance and operations, corporate development, investor relations, treasury, and strategic initiatives including fundraising.

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the launch of Drone as a Service specifically for US Defense and Government agencies, and two new partnerships with consulting and government relations firms to assist in selling these services. ZenaTech's ZenaDrone subsidiary has retained the services of Bromelkamp Government Relations and Winning Strategies Washington to provide Congressional lobbying and defense business development consulting services.

KIRKLAND, Wash., June 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.

Denver, Colorado, June 05, 2025 (GLOBE NEWSWIRE) -- authID, a leading provider of identity proofing and biometric authentication, today announced a new integration with Ping Identity, a leader in securing digital identities for the world's largest enterprises. authID will leverage PingOne DaVinci™, a no-code identity orchestration service, enabling organizations to quickly and easily adopt privacy-preserving biometrics, which will help them eliminate the need for passwords and mitigate account takeover fraud.

Access the on-demand webcast here HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the release of its Soft Tissue Sarcoma (STS) Lung Mets KOL Webcast discussing the final data from its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung metastases (MB-107). For the event, Walter Klemp, Chairman and Chief Executive Officer, and Dr. Paul Waymack, Senior Chief Medical Officer of Moleculin are joined by Key …

EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment options The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat combination therapy across multiple study endpoints, including overall survival in both the entire population and key subpopulations, when compared to standard of care alone BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated …

HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NiCE (Nasdaq: NICE) today announced the winners of its 2025 International Partner Awards at the Partner Summit events held in Croatia and Thailand. These honorees are helping our customers drive innovation, meet ambitious timelines, and deliver success in the new era of customer service automation with CXone Mpower. Winners were recognized across several categories. Standout partner wins included: UK&I Partner of the Year – A 23-year partnership excelling in.

Key Highlights: Among the First Renewable Energy Companies to Implement Bitcoin Treasury Strategy 3.79 MW Geddes Project Expected to Generate Revenue Starting this Month 1+ Gigawatt Development Pipeline Positions Company for Growth Joining Other Forward-Thinking Corporations in Bitcoin Adoption TORONTO , June 5, 2025 /PRNewswire/ - SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) ("SolarBank" or the "Company") a leader in distributed solar energy, battery storage, and clean energy infrastructure across North America, announced today that further to the announcement of its Bitcoin treasury strategy on June 3 rd, it is taking the first step in implementing this strategy …

PETACH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd, has received EU MDR CE (Conformité Européenne) mark certification for HealthOST, an SaMD (Software as a medical device) for bone health analysis, enabling its commercialization across Europe and ensuring compliance with the highest regulatory standards for medical software.

Acquisition will add approximately $1.8 million in annual revenue and increases network of animal hospitals to 14 VIRGINIA BEACH, VA / ACCESS Newswire / June 5, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., announced today it has acquired 100% ownership interest in DeBary Animal Clinic in DeBary Florida, north of Orlando. The acquisition marks the Company's fifth in the state and is projected to add up to approximately $1.8 million in annualized revenue to Inspire's growing veterinary clinic network.

ROSH HA‘AYIN, IL / ACCESS Newswire / June 5, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of Thermal Energy Storage ("TES") solutions for industrial and utility customers,today issued a shareholder update from its Chairman and Chief Executive Officer, Avi Brenmiller.